Skip to Content

ALTACE 1.25 mg MP (Altace 1.25 mg)

Generic Name: ramipril

Pill with imprint ALTACE 1.25 mg MP is Yellow, Capsule-shape and has been identified as Altace 1.25 mg. It is supplied by Monarch Pharmaceuticals, Inc..

Altace is used in the treatment of high blood pressure; left ventricular dysfunction; diabetic kidney disease; cardiovascular risk reduction; heart failure (and more), and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Altace 1.25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for ALTACE 1.25 mg MP

Altace 1.25 mg ALTACE 1.25 mg MP
Altace 1.25 mg ALTACE 1.25 mg MP Front
Altace 1.25 mg ALTACE 1.25 mg MP Back
Altace 1.25 mg ALTACE 1.25 mg MP


Generic Name:
ALTACE 1.25 mg MP
1.25 mg
4.00 mm
Prescription only
Drug Class:
Angiotensin Converting Enzyme Inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Monarch Pharmaceuticals, Inc.
Inactive Ingredients:
corn starch
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.